VISTAGEN THERAPEUTICS, INC. Notes Payable, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Notes Payable, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Notes Payable, Current $0.00.
- 2026-03-31: Notes Payable, Current $96.00K.
- 2025-12-31: Notes Payable, Current $379.00K.
- 2025-09-30: Notes Payable, Current $658.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 |
| 2026-03-31 | $96.00K 10-Q · filed 2026-08-14 |
| 2025-12-31 | $379.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $658.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $933.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-02-12 |
| 2024-03-31 | $0.00 10-K · filed 2024-06-11 |
| 2023-03-31 | $105.00K 10-K · filed 2024-06-11 |
| 2021-03-31 | $0.00 10-K · filed 2021-06-29 |
| 2020-03-31 | $56.50K 10-K · filed 2021-06-29 |
| 2019-03-31 | $57.30K 10-K · filed 2020-06-29 |
| 2018-03-31 | $53.90K 10-K · filed 2019-06-25 |
| 2017-03-31 | $54.80K 10-K · filed 2018-06-26 |
| 2016-03-31 | $43.60K 10-K · filed 2017-06-29 |
| 2015-03-31 | $4.12M 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |